PSMA-Targeted radiopharmaceuticals: from diagnosis to risk & quality of life
- PMID: 40779069
- DOI: 10.1007/s00259-025-07507-5
PSMA-Targeted radiopharmaceuticals: from diagnosis to risk & quality of life
Conflict of interest statement
Declarations. Study-specific approval by the appropriate ethics committee for research involving humans and/or animals: Not available. Informed consent: Not required.
References
-
- Kasivisvanathan V, Chan VWS, Clement KD, Levis B, Ng A, Asif A, et al. Vision: an individual patient data meta-analysis of randomised trials comparing magnetic resonance imaging targeted biopsy with standard transrectal ultrasound guided biopsy in the detection of prostate cancer. Eur Urol. 2025;87:512–23. - PubMed - DOI
-
- Dushimova Z, Iztleuov Y, Chingayeva G, Shepetov A, Mustapayeva N, Shatkovskaya O, et al. Overdiagnosis and overtreatment in prostate cancer. Dis. 2025;13:167.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
